TRIGLYCERIDE-RICH LIPOPROTEINS AND THE PROGRESSION OF CORONARY-ARTERY DISEASE

被引：114
作者：
HODIS, HN
MACK, WJ
机构：
[1] UNIV SO CALIF, SCH MED,DEPT MED,DIV CARDIOL, ATHEROSCLEROSIS RES UNIT, LOS ANGELES, CA USA
[2] UNIV SO CALIF, SCH MED, DEPT PREVENT MED, LOS ANGELES, CA 90033 USA
来源：
CURRENT OPINION IN LIPIDOLOGY | 1995年 / 6卷 / 04期
关键词：
D O I：
10.1097/00041433-199508000-00004
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A growing body of evidence from serial coronary angiographic studies indicates that triglyceride-rich lipoproteins are an important factor in the progression of coronary artery disease. Compelling evidence also suggests that triglyceride-rich lipoproteins may be most important in the progression of mild-moderate lesions, the very lesions that are likely to be responsible for clinical coronary events.
引用
收藏
页码：209 / 214
页数：6
相关论文
共 24 条
[1]   DAVID RUBINSTEIN MEMORIAL LECTURE - THE BIOCHEMICAL AND CLINICAL-SIGNIFICANCE OF THE INTERRELATIONSHIP BETWEEN VERY LOW-DENSITY AND HIGH-DENSITY LIPOPROTEINS [J].
ALAUPOVIC, P .
CANADIAN JOURNAL OF BIOCHEMISTRY, 1981, 59 (08) :565-579
[2]  
ALAUPOVIC P, 1991, J LIPID RES, V32, P9
[3]   EFFECTS OF LOVASTATIN ON APOA-CONTAINING AND APOB-CONTAINING LIPOPROTEINS - FAMILIES IN A SUBPOPULATION OF PATIENTS PARTICIPATING IN THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].
ALAUPOVIC, P ;
HODIS, HN ;
KNIGHTGIBSON, C ;
MACK, WJ ;
LABREE, L ;
CASHINHEMPHILL, L ;
CORDER, CN ;
KRAMSCH, DM ;
BLANKENHORN, DH .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (12) :1906-1914
[4]   PLASMA TRIGLYCERIDE AND CORONARY HEART-DISEASE [J].
AUSTIN, MA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :2-14
[5]   PLASMA-LIPID CONCENTRATIONS AND SUBSEQUENT CORONARY-OCCLUSION AFTER A 1ST MYOCARDIAL-INFARCTION [J].
BISSETT, JK ;
WYETH, RP ;
MATTS, JP ;
JOHNSON, JW .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1993, 305 (03) :139-144
[6]   CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].
BLANKENHORN, DH ;
AZEN, SP ;
KRAMSCH, DM ;
MACK, WJ ;
CASHINHEMPHILL, L ;
HODIS, HN ;
DEBOER, LWV ;
MAHRER, PR ;
MASTELLER, MJ ;
VAILAS, LI ;
ALAUPOVIC, P ;
HIRSCH, LJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976
[7]   PREDICTION OF ANGIOGRAPHIC CHANGE IN NATIVE HUMAN CORONARY-ARTERIES AND AORTOCORONARY BYPASS GRAFTS - LIPID AND NONLIPID FACTORS [J].
BLANKENHORN, DH ;
ALAUPOVIC, P ;
WICKHAM, E ;
CHIN, HP ;
AZEN, SP .
CIRCULATION, 1990, 81 (02) :470-476
[8]   ARTERIAL IMAGING AND ATHEROSCLEROSIS REVERSAL [J].
BLANKENHORN, DH ;
HODIS, HN .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (02) :177-192
[9]   BENEFICIAL-EFFECTS OF COLESTIPOL-NIACIN THERAPY ON THE COMMON CAROTID-ARTERY - 2-YEAR AND 4-YEAR REDUCTION OF INTIMA-MEDIA THICKNESS MEASURED BY ULTRASOUND [J].
BLANKENHORN, DH ;
SELZER, RH ;
CRAWFORD, DW ;
BARTH, JD ;
LIU, CR ;
LIU, CH ;
MACK, WJ ;
ALAUPOVIC, P .
CIRCULATION, 1993, 88 (01) :20-28
[10]   BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240
123